# Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis

> **NCT04604652** · PHASE2 · COMPLETED · sponsor: **HighTide Biopharma Pty Ltd** · enrollment: 24 (actual)

## Conditions studied

- Primary Biliary Cholangitis
- Primary Biliary Cirrhosis
- Cholangitis
- Cholestasis
- Biliary Tract Diseases
- Bile Duct Stricture

## Interventions

- **DRUG:** HTD1801 (BUDCA)

## Key facts

- **NCT ID:** NCT04604652
- **Lead sponsor:** HighTide Biopharma Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-27
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04604652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04604652, "Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04604652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*